Tech Company Financing Transactions
AEGEA Funding Round
On 11/13/2018, AEGEA raised $17 million in investment from Solas Bioventures and private investors.
Transaction Overview
Company Name
Announced On
11/13/2018
Transaction Type
Venture Equity
Amount
$17,000,000
Round
Undisclosed
Investors
Solas Bioventures (Lead Investor) (David Adair)
Proceeds Purpose
The proceeds will be used to fund AEGEA's prospective, multi center Post-Ablation Cavity Access (PACE II) study to evaluate uterine cavity access and the possibility of minimally invasive interventions three to four years following ablation treatment.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4055-A Campbell Ave.
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
The AEGEA Vapor System utilizes water vapor to treat menorrhagia. Water vapor efficiently enables the body to naturally eliminate unwanted tissue.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Maria Sainz
Chief Financial Officer
John Beck
Chief Medical Officer
Micah Harris
Chief Technical Officer
Donald Gurskis
VP - Operations
Thomas Kelly
VP - R & D
Hiram Chee
VP - Regulatory Affairs
Alexis Dineen
VP - Regulatory Affairs
Connie Rey
Browse more venture capital transactions:
Prev: 11/13/2018: Harpoon Therapeutics venture capital transaction
Next: 11/13/2018: Clearbanc venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs